The Division of Neuro
Our focus is neurological diseases, brain and spinal cord injuries. The aim of our research is to better understand the cause of disease in the nervous system with the perspective of revealing new and better treatments, such as for multiple sclerosis, stroke, brain tumors, epilepsy and Parkinson's disease. We conduct both research and teaching in close collaboration with the clinics.
Our core activities are research and education. Our research is at the leading edge both nationally and internationally and is very important in our close collaboration with the healthcare. We have many international and national collaborators and we always welcome new partners. We are active both in Solna and Huddinge.
We are 25 research groups conducting high quality research. Our focus is neurological diseases such as multiple sclerosis, stroke, brain tumors, epilepsy and Parkinsons disease, brain and spinal cord injuries.
Research areas A-Ö
A list of research areas
Research group leaders A-Ö & Research groups
A list of group leaders, their research groups and research areas.
Teaching is an important part of the activity in the Neuro section. We work together in the education of medical doctors (MD), nurses, physiotherapists, occupational therapists and biomedical scientists.
PhD defenses / Dissertations
Previous Dissertations & information for PhD students'
Upcoming activities, events, seminars, division meetings, dissertations etc, at the Division of Neuro
Brain & Mind
Brain & Mind is an academic environment that brings together researchers in cognitive neuroscience. We use various forms of brain imaging to better understand brain function, both in health and disease. Together we provide a unique environment for collaboration and scientific exchange in order to create world-leading research on the human brain.
KI student wins first prize in an international thesis award
Medical student Julie Cheung from Karolinska Institutet (KI), affiliated with Eric Thelin's research group, recently won first prize at the prestigious Global Undergraduate Awards thesis competition in the category of Medical Sciences.
Prosaposin could be a promising drug candidate for Parkinson’s disease
Nature Communications has published a new study by researchers from Per Svenningsson's research group at the Division of Neuro. The results of the study provide increased mechanistic understanding of how Parkinsonism occurs and show that increased levels of prosaposin can counteract Parkinsonism and is a new candidate for drug development.
Link to the publication: "Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents"
Targeting Epstein-Barr virus to treat and prevent MS
University of Bergen in collaboration with researchers at the Department of Clinical Neuroscience at Karolinska Institutet, have been awarded a significant grant funded by Horizon Europe with €7 million during 2024-2028 in recognition of their dedication to target Epstein-Barr virus to treat and prevent Multiple Sclerosis.
Karin Jensen new professor at the Department of Clinical Neuroscience
On July 1, 2023, our research group leader Karin Jensen was employed as professor at the Department of Clinical Neuroscience (CNS).
New gene discovery gives hope of fighting severe MS
A new study in Nature by an international team including researchers at Karolinska Institutet has identified the first genetic variant associated with disease severity in multiple sclerosis. Ingrid Kockum at the Department of Clinical Neuroscience, and principal investigator for the European part of the study, says that this gives us an opportunity to develop new treatments to control progression, which is urgently needed by so many people suffering from MS.
New study explains how a common virus can cause multiple sclerosis
Researchers at Karolinska Institutet, Olivia Thomas and Mattias Bronge in Hans Grönlund's research group, have found further evidence for how the Epstein-Barr virus can trigger multiple sclerosis or drive disease progression.
CNS researchers among Sweden's top 100 researchers in 2023
Tomas Olsson at the Division of Neuro has been ranked as #35 by the leading academic platform Research.com of the country's top researchers in 2023 in the medical field. This is the highest ranking in the Department of Clinical Neuroscience.
Major EU funding for development of AI in healthcare
Researchers at Karolinska Institutet, the Centre for Imaging Research (CIR), SciLifeLab, and RISE have together received a grant of over SEK 100 million from the European Commission's Digital Europe programme. The project, called TEF-Health, will, among other things, promote the rapid introduction of new artificial intelligence (AI) and robotics solutions in healthcare.
Niaz Ahmed new adjunct professor at CNS/Neuro
On October 4, 2022, our research group leader Niaz Ahmed was employed as an adjunct professor at the Department of Clinical Neuroscience, CNS, the Division of Neuro.
Agreement signed with the digital research infrastructure EBRAINS
Karolinska Institutet has signed a collaboration agreement with the European research infrastructure EBRAINS, which offers digital tools and services for research into the brain. The purpose of this agreement is to give KI's researchers access to new digital technology and state-of-the-art resources, as well as the opportunity to contribute to the further development of the area of neuroscience within the EU.
New grant from the Swedish Research Council makes KI's brain-imaging lab NatMEG world-class
The national MEG lab at Karolinska Institutet is already the only lab in Sweden with equipment to measure neuronal brain activity in real time across the entire brain. Now, a new sensor-system upgrade to its technical equipment will make the lab an international leader in the field.
Staffan Holmin is awarded the Prize for Innovation and Utilization, 2022
Staffan Holmin at the Department of Clinical Neuroscience at Karolinska Institutet, is awarded the Prize for Innovation and Utilization, 2022. The prize recognizes one or more researchers/research students who have distinguished themselves through outstanding utilization of research results that have led to innovation.
Brain differences in pain modulation in people with self-injury behaviour
Researchers at Karolinska Institutet in Sweden might have found an explanation for why people with self-injury behaviour generally feel less pain than others. The key seems to be a more effective pain-modulation system, a discovery that can benefit people seeking help for their self-harm. The findings are published in the journal Molecular Psychiatry.
Findings open way for personalised MS treatment
Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at KI have now developed a method for identifying the immune cells involved in autoimmune diseases, and have identified four new target molecules of potential significance for future personalised treatment of MS. Working alongside Professor Tomas Olsson’s research group at Karolinska Institutet, Grönlund and his team at the Division of Neuro have developed a method that makes it possible to identify the T cells that react to certain target molecules – so called autoantigens.
StratNeuro 2022 Startup Grant to Jeroen Goos
StratNeuro has awarded SEK 1,000,000 in start-up grant 2022 to Enric Llorens, Arvid Guterstam and Jeroen Goos. The StratNeuro Start-up Grant is intended to support outstanding Neuroscience researchers at the beginning of their careers, who have received a VR starting grant or a Karolinska Institutet assistant professor grant.
The gut-brain axis in Parkinson’s disease
Interesting thesis from one of our colleagues at the Department of Medical Epidemiology and Biostatistics, on the importance of the connection between the brain and the gut for Parkinson´s disease
Celebrating 1 year of NeurotechEU – where are we and where are we going?
A digital 1-day meeting attended by 300 participants brought neuroscience researchers from across Europe together to reflect on both progress to date and plans for the future for the collaborative European University Initiative (EUI) focusing on neurochallenges.
When the pain itself is the illness
Eva Kosek has been researching pain mechanisms for many years. Now she and her colleagues have developed criteria for calling in so-called nociplastic pain. It is a condition in which pain is not just a symptom but a disease in itself.
New findings on how ketamine acts against depression
The discovery that the anaesthetic ketamine can help people with severe depression has raised hopes of finding new treatment options for the disease. Researchers at Karolinska Institutet have now identified novel mechanistic insights of how the drug exerts its antidepressant effect. The findings have been published in the journal Molecular Psychiatry.